April 8 (Reuters) - Some U.S. stocks on the move on Monday:
Wall Street waned as investors faced the prospect of a lackluster corporate earnings season and an economy that could be hitting a slow patch.
The Dow Jones industrial average was down 44.00 points, or 0.30 percent, to 14,521.25, the Standard & Poor’s 500 Index lost 2.75 points, or 0.18 percent, to 1,550.53 and the Nasdaq Composite Index lost 3.34 points, or 0.10 percent, to 3,200.52.
** LUFKIN INDUSTRIES INC, $87.88, up 37.4 pct (1152 ET)
** GENERAL ELECTRIC CO, $22.85, down 0.4 pct (1152 ET)
General Electric is buying oilfield pump maker Lufkin Industries for $2.98 billion, sharply increasing its presence in the fast-growing market to extract oil and natural gas from shale rock, the conglomerate said on Monday.
** WEATHERFORD INTERNATIONAL LTD, $12.52, up 4 pct (1153 ET)
Shares of the Lufkin rival were also up on Monday. MVL & Co analyst William Conroy said Lufkin and Weatherford are direct competitors in the artificial lift segment and together control about 95 percent of the market. “The share movement that we can see is the follow-on enthusiasm with the Lufkin announcement,” Conroy said.
** GLOBAL-TECH ADVANCED INNOVATIONS INC, $7.18, down 11 percent (1151 ET)
The maker of metal oxide semiconductor and camera modules reported a drop in profit and sales as customers chose to buy its low-cost camera modules rather than the high-margin ones.
Shares of the company were one of the top percentage losers on the Nasdaq on Monday.
** BIOCRYST PHARMACEUTICALS INC, $2.11, up 24 pct (1154 ET)
** SINOVAC BIOTECH LTD, $3.75, down 4 pct (1138 ET)
Shares of BioCryst, which is developing an intravenous anti-viral agent to treat the influenza virus, surged on the rise in the number of people in China infected by the bird flu that is caused due to a new virus strain. As of Monday, the number of people infected rose to 24, with seven deaths.
China’s Food and Drug Administration on Saturday said it had given a fast-tracked approval for BioCryst’s intravenous anti-influenza drug Peramivir.
Shares of rival Sinovac, which develops vaccines for a strain of bird flu, fell 4 percent.
** SKECHERS USA INC, $21.70, up 5 pct (1147 ET)
Susquehanna raised its first-quarter earnings estimates on the shoemaker to 20 cents from 18 cents and said momentum at the company continues to remain strong and broad based.
“Positive commentary from key retail accounts in addition to strong market share gains give us comfort in our first-quarter sales and earnings estimates,” analyst Christopher Svezia wrote in a note adding that international sales remain favorable, including growth across Europe.
** TRINA SOLAR LTD, $3.74, up 5 pct (1155 ET)
The Chinese solar panel maker hopes it can snap out of losses from June, its chairman said on Saturday, as it banks on China’s rising demand for green energy and an easing in excess global supply. While the industry may face another turbulent year, Trina Chairman Gao Ji was optimistic as he looked to expanding Chinese demand.
** RUBICON TECHNOLOGY INC, $7.14, up 11 pct (1156 ET)
Sterne Agee upgraded the advanced electronic materials provider to “buy” from “neutral,” saying it believes industry fundamentals are about to improve on higher demand for sapphire substrates -- a key component used in manufacturing LEDs.
Analyst Andrew Huang said pricing has likely bottomed, with many suppliers now trying to raise price. “We expect pricing for both core and wafers to increase slightly Q/Q (quarter over quarter) for the June quarter and again for the September quarter.”
** UNIPIXEL INC, $28.12, up 4 pct (1156 ET)
The LCD film maker said it signed a multi-million deal with a “major touch-screen ecosystem partner” to produce touch screens with multi-touch sensor film.
** NOMURA HOLDINGS INC , $6.8, up 5 pct (1033 ET)
The yen slumped against the dollar and the euro on Monday as the Bank of Japan began its boldest economic boost yet. The dollar rallied to 99 yen, its highest since May 2009, and the euro touched a three-year peak against the Japanese currency after the BoJ conducted its first bond purchases since announcing the new monetary easing steps last week.
** EPL OIL & GAS INC, $29.80, up 7 pct (1141 ET)
CapitalOne upgraded the oil and gas producer’s stock to “strong buy” from “add”, according to StreetInsider.com.
** CIA ENERGETICA DE MINAS GERAIS ; $11.65; down 5 pct (1055 ET)
The Brazilian power company said on Friday that it its rates will increase 2.99 percent for the next four years, less than that suggested by the country's regulator. The increase, to be implemented from April 8, is well below the initial forecast adjustment of 6.36 percent. (link.reuters.com/kev27t)
** CERAGON NETWORKS , $3.89, down 8 pct (1142 ET)
The Israeli telecom equipment maker estimated first-quarter revenue between $89 million and $91 million, below its previous forecast, as it took longer to close certain deals.
** GOL LINHAS, $5.89, up 10.7 pct (1044 ET)
Gol Linhas Aéreas Inteligentes SA plans to raise up to 1.35 billion reais ($681 million) in the initial public offering of its Smiles SA customer loyalty unit, Brazil’s No. 2 airline said on Monday in a regulatory announcement in an effort to buttress the company as it faces several challenges.
** CENTRAL EUROPEAN DISTRIBUTION CORP, $0.18, down 41 pct (1200 ET)
Poland’s Central European Distribution Corp has filed for a pre-packaged bankruptcy that will give Russian businessman Roustam Tariko full control of the vodka producer, a court filing showed.
** NATIONAL BANK OF GREECE, $0.64, down 10 pct (1158 ET)
National Bank and rival Eurobank confirmed their merger deal had been halted and they are unlikely to raise the private capital they need to stay out of state hands.
** BSD MEDICAL CORP, $1.68, up 19 pct (1158 ET)
The medical device maker said it entered into a deal with Terumo Europe NV to market BSD Medical’s heat utilizing cancer therapy system, MicroThermX, in Europe, Western Asia, and Northern Africa.
** EDAC TECHNOLOGIES CORP, $17.68, 4.5 pct down (1157 ET)
The aerospace components maker said MidOcean Partners and PSP Investments are withdrawing their unsolicited offer to acquire the company at $18.25 per share. EDAC said its board continues to recommend GB Aero Engine Merger Sub Inc’s offer of $17.75 per share.
** OBAGI MEDICAL PRODUCTS INC, $23.93, down 6 pct (1043 ET)
Germany’s Merz Pharma Group withdrew its offer for the U.S. cosmetic products maker, after rival bidder Canada’s Valeant Pharmaceuticals International Inc raised its offer last week.
** ANACOR PHARMACEUTICALS INC, $6.63, up 10.6 pct (1034 ET)
The biopharmaceutical company said it would get $17.7 million from the Bill & Melinda Gates Foundation to discover drugs to treat tuberculosis, river blindness and elephantiasis. The foundation will also invest $5 million in Anacor’s common stock, as part of the research and development agreement with the company.
** EXAMWORKS GROUP INC, $18.18, up 7 pct (1154 ET)
Credit Suisse analyst Ralph Giacobbe raised his target price on the company’s stock to $21 from $18, saying that the independent medical examinations provider can meet its organic growth target on the strength of its three national contracts in the United States and the U.K.
** ACELRX PHARMACEUTICALS INC, $5.1, up 1.4 pct (1034 ET)
Jefferies on Friday initiated coverage on the drug developer’s stock with a “buy” rating and a price target of $8, on expectation that AcelRx’s ARX-01, a drug-device combination to manage pain, will be approved by U.S. health regulators in 2014. “We see a clear market opportunity for ARX-01 given the current standard of care for post-op pain control is fraught with drawbacks,” analyst Corey Davis wrote in a note to clients.
** GLU MOBILE INC, $3.12, up 10.2 pct (1035 ET)
The mobile games maker entered into a change of control severance agreement with its President of Studios Matthew Ricchetti, the company said in a filing on Friday. "It is expected that the company from time to time will consider the possibility of a change of control," the filing said. (link.reuters.com/syt27t)
The agreement hints the company could be acquired, a Seeking Alpha article said on Saturday. (link.reuters.com/tyt27t)
** AMARIN CORP, $7.30, up 1.5 pct (1036 ET)
The pharmaceutical company said additional data from a late-stage study of its approved heart drug, Vascepa, showed the drug reduced the levels of a protein which stopped the removal of triglycerides from blood. Triglycerides is a type of fat which hardens arteries and raises the chance of heart disease.
** DELCATH SYSTEMS INC, $1.67, down 5.1 pct (1039 ET)
The pharmaceutical and medical device company said the U.S. health regulator delayed the date of the final decision on its drug device combination product aimed to treat liver cancer. Delcath said the FDA requested certain information on March 18, which was provided by the company, following which the FDA pushed the review date to Sept. 13.
** RADIAN GROUP INC, Friday close $10.55, up 4 pct (1039 ET)
Macquarie Equities Research upgraded the mortgage insurer to “outperform” from “neutral,” according to the TheFlyOnTheWall.com.
** CONSTELLATION BRANDS INC, $48.82, up 2 pct (1050 ET)
Anheuser-Busch InBev and the U.S. Justice Department have reached an agreement for a framework to settle their long-running beer brawl, and asked a court to extend a stay in the court fight until April 23, the two sides said in a court filing on Friday.
The Justice Department filed a lawsuit on Jan. 31 aimed at stopping AB InBev, the world’s largest brewer from buying the 50 percent of Grupo Modelo it does not already own for $20.1 billion, saying the deal could mean higher U.S. beer prices. AB InBev had then said it would sell its 50 percent share of Modelo’s U.S. distributor, Crown Imports, to Constellation Brands, the world’s largest branded wine company.
** FIRST NIAGARA FINANCIAL GROUP, $8.90, up 2.5 pct (1037 ET)
Brokerage KBW raised its rating on the lender’s stock to “outperform,” saying the recent management change was a long-term catalyst for the shares. Evercore Partners also upgraded the bank’s stock to “equalweight” from “underweight.”
First Niagara’s CEO John Koelmel resigned last month. The board formed a special committee to find a replacement. (Compiled by Aditi Shrivastava in Bangalore; Editing by Supriya Kurane)